Viatris Stock
StockStockPrice
Historical dividends and forecast
Viatris has so far distributed $0.36 in 2024. The next dividend will be paid on 13.12.2024
CHART BY
Frequently asked questions
What is Viatris's market capitalization?
What is the Earnings Per Share (EPS) for Viatris?
What are the analyst ratings and target price for Viatris's stock?
What is Viatris's revenue over the trailing twelve months?
Is Viatris paying dividends?
What is the EBITDA for Viatris?
What is the free cash flow of Viatris?
What is the 5-year beta of Viatris's stock?
How many employees does Viatris have, and what sector and industry does it belong to?
What is the free float of Viatris's shares?
Financials
Market Cap
$15.52B5Y beta
0.95EPS (TTM)
-$0.739Free Float
1.19BRevenue (TTM)
$15.05BEBITDA (TTM)
$4.14BFree Cashflow (TTM)
$1.32BPricing
Analyst Ratings
The price target is $12.33 and the stock is covered by 8 analysts.
Buy
1
Hold
5
Sell
2
Information
Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s ARV franchise. The Company’s portfolio comprises approved molecules across a range of key therapeutic areas, including globally recognized iconic and key brands and generics, including complex products. The Company operates manufacturing sites across worldwide that produce oral solid doses, injectables and complex dosage forms.
38,000
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker